Alogliptin and Dolutegravir Interaction

Drug interaction information between Alogliptin and Dolutegravir.

Alogliptin and Dolutegravir have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Alogliptin and Dolutegravir. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Alogliptin

DPP-4 Inhibitor

Drug B

Dolutegravir

Integrase Strand Transfer Inhibitor

How They Interact

Dolutegravir can slow down how quickly the body removes metformin. This can cause metformin to build up in the blood, increasing the risk of side effects.

FDA Label Information

( 7 ) Drugs that reduce metformin clearance (such as ranolazine, vandetanib, dolutegravir, and cimetidine), may increase the accumulation of metformin. Examples: Ranolazine, vandetanib, dolutegravir, and cimetidine Alcohol Clinical Impact: Alcohol is known to potentiate the effect of metformin on lactate metabolism.

Frequently Asked Questions

What SPL severity band is on file for Alogliptin + Dolutegravir?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Dolutegravir has 28 labeled pairs on file vs Alogliptin's 7. In the minor band specifically: Alogliptin has 5 (also Metformin, Ranolazine, Cimetidine, Phenytoin); Dolutegravir has 21 (also Omeprazole, Prednisone, Estradiol, Carbamazepine).

What mechanism field is on file for Alogliptin and Dolutegravir?

Dolutegravir can slow down how quickly the body removes metformin. This can cause metformin to build up in the blood, increasing the risk of side effects.

Dolutegravir carries more major-labeled pairs than Alogliptin

SPL source-record counts only. This page's band is minor · classes on file: Alogliptin (DPP-4 Inhibitor); Dolutegravir (Integrase Strand Transfer Inhibitor).

Dolutegravir has 1 major-labeled pair vs Alogliptin's 0. This page itself is in the minor band, not the major band.

Alogliptin

0 major · 2 moderate · 5 minor · 7 total

Dolutegravir

1 major · 6 moderate · 21 minor · 28 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.